Icon

GLUCOVANCE (nda021178)- (1.25MG;250MG,2.5MG;500MG,5MG;500MG)

GLYBURIDE; METFORMIN HYDROCHLORIDE BRISTOL MYERS SQUIBB
1.25MG;250MG,2.5MG;500MG,5MG;500MG
Yes Yes
2020-Jan-14 Expired
None None
None No
GLUCOVANCE is a combination of glyburide, a sulfonylurea, and metformin hydrochloride (HCl), a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
4 0 2
Total Other Developers 1
Drugs with Suitability No
1.25MG;250MG ** ** - 1 -
2.5MG;500MG ** ** - - 1
5MG;500MG ** ** - - 1
NDA Sales Available Total Generic Sales Available
No 1
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ********* ****** ********* ****** ******* *********** ****-***, **. **.*** & ***, **********, ********** ******, *******-********** ********, *******, ********* ******, ***** (***) ***
****** ***** ****** ***** ************ ******* *********** ******* ****** *****, *.*. *****, ******-********, *****, ******** ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.